Eighty products with estimated sales of £160.5m were added to the UK database in November.
Seventy-one plans struck during the month compared to 63 in October. Some 734 products worth an estimated £1.5 billion have struck in 2022 year to date – up 66% by sales volume and 63% by issuance compared to the prior year period (Jan to Nov 21: £909m from 450 products). Twenty-three investments ran to the end of their life cycle while another 23 autocalled. Société Générale's UK Defensive Growth Plan 15 (UK Four) was the best performing product,
Continue reading with a subscription to the SRP market intelligence platform.
Request DemoAlready a subscriber? Login